AssayIndex
Reports by quarter

Reports submitted in 2024-Q2

First quarter of live submission. Median purity for the quarter is 99.10 % area, n=287. Read the 2024-Q2 state-of-the-index report →

287 records8 pagesmedian on this page 99.13 %updated 30 Jul 2026
012243692.093.094.095.096.097.098.099.0100.092.00–92.25 %: n=092.25–92.50 %: n=092.50–92.75 %: n=092.75–93.00 %: n=093.00–93.25 %: n=093.25–93.50 %: n=093.50–93.75 %: n=093.75–94.00 %: n=094.00–94.25 %: n=094.25–94.50 %: n=094.50–94.75 %: n=094.75–95.00 %: n=095.00–95.25 %: n=095.25–95.50 %: n=095.50–95.75 %: n=095.75–96.00 %: n=096.00–96.25 %: n=096.25–96.50 %: n=096.50–96.75 %: n=096.75–97.00 %: n=297.00–97.25 %: n=097.25–97.50 %: n=797.50–97.75 %: n=397.75–98.00 %: n=1298.00–98.25 %: n=2398.25–98.50 %: n=2398.50–98.75 %: n=3698.75–99.00 %: n=2599.00–99.25 %: n=3899.25–99.50 %: n=3899.50–99.75 %: n=4299.75–100.00 %: n=38median 99.10 Purity (% area) Reports
Figure. Purity distribution for reports submitted in 2024-Q2. n=287, median 99.10 % area. Same fixed 92–100 % domain as every other purity histogram on this site, so quarters can be compared by eye.
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2024-004850TirzepatideERPERP-2401-D8257Janoshik2024-Q298.424.67—Buyer-sourced0PASS
AX-2024-004636AOD-9604TFCTFC-2402-L2242Kestrel2024-Q299.775.6988.7Buyer-sourced1MARGINAL
AX-2024-005023SermorelinKPKP-2312-R5133Janoshik2024-Q299.386.59106.4Buyer-sourced0PASS
AX-2024-005198GHRP-6CPCCPC-2401-N1934VendorInvestigate2024-Q299.585.48100.7Buyer-sourced1MARGINAL
AX-2024-004848TB-500ERPERP-2401-K8556Nordanalyt2024-Q299.283.02—Laboratory-retained0PASS
AX-2024-004676SemaglutideHomopeptideHOMO-2401-R3356PeptideMeter2024-Q298.562.65—Buyer-sourced0PASS
AX-2024-004666TirzepatideTFCTFC-2312-P3229Janoshik2024-Q298.002.51105.6Buyer-sourced0PASS
AX-2024-005197GHRP-6CPCCPC-2401-N1934VendorInvestigate2024-Q299.495.51—Buyer-sourced1MARGINAL
AX-2024-004789L-CarnosineHomopeptideHOMO-2405-P5405PeptideMeter2024-Q299.466.3290.6Buyer-sourced0PASS
AX-2024-004780RetatrutideHomopeptideHOMO-2311-R5976Janoshik2024-Q298.722.58—Supplier-supplied0PASS
AX-2024-004183Kisspeptin-10WWBWWB-2311-T3203VendorInvestigate2024-Q299.346.3297.8Buyer-sourced0PASS
AX-2024-004635AOD-9604TFCTFC-2402-L2242Janoshik2024-Q299.275.62—Buyer-sourced0PASS
AX-2024-004683SemaglutideHomopeptideHOMO-2401-R3356Janoshik2024-Q298.722.49—Buyer-sourced0PASS
AX-2024-004783RetatrutideHomopeptideHOMO-2311-R5976Janoshik2024-Q298.053.5594.8Buyer-sourced0PASS
AX-2024-004854TirzepatideERPERP-2401-D8257PeptideMeter2024-Q298.554.4597.0Buyer-sourced0PASS
AX-2024-004840PT-141 (Bremelanotide)SWBSWB-2311-H8764Janoshik2024-Q299.073.1892.7Buyer-sourced1MARGINAL
AX-2024-004250SermorelinQYBQYB-2404-W4423Janoshik2024-Q299.713.58102.1Buyer-sourced0PASS
AX-2024-005287CagrilintideBCHBCH-2402-C5045Medutest2024-Q297.373.98—Buyer-sourced0PASS
AX-2024-005224SemaxWXTWXT-2402-W2466PeptideMeter2024-Q298.557.03—Buyer-sourced0PASS
AX-2024-004906BPC-157ERPERP-2402-D9383Janoshik2024-Q299.336.6996.4Buyer-sourced0PASS
AX-2024-005378L-Glutathione (reduced)PPGPPG-2312-C7508Medutest2024-Q299.887.6490.1Buyer-sourced0PASS
AX-2024-005223SemaxWXTWXT-2402-W2466Janoshik2024-Q298.916.82—Buyer-sourced0PASS
AX-2024-004980SemaglutideMKMMKM-2403-C4617Janoshik2024-Q299.136.26104.5Buyer-sourced0PASS
AX-2024-004846TB-500ERPERP-2401-K8556Medutest2024-Q299.273.0790.3Buyer-sourced0PASS
AX-2024-004972SemaglutideMKMMKM-2403-C4617PeptideMeter2024-Q298.765.8095.4Buyer-sourced0PASS
AX-2024-004549SS-31 (Elamipretide)JEEPJEEP-2403-M8097VendorInvestigate2024-Q299.133.6694.1Buyer-sourced0PASS
AX-2024-005154TirzepatideSGNSGN-2401-K9783Kestrel2024-Q299.724.08105.6Supplier-supplied1MARGINAL
AX-2024-004824TirzepatideSWBSWB-2311-B7511PeptideMeter2024-Q297.297.2798.4Buyer-sourced0PASS
AX-2024-004823TirzepatideSWBSWB-2311-B7511Janoshik2024-Q297.417.6795.7Buyer-sourced0PASS
AX-2024-004533SelankHYBHYB-2405-C7630PeptideMeter2024-Q299.707.0898.8Buyer-sourced0PASS
AX-2024-004502CJC-1295 (no DAC)HYBHYB-2405-B6705Medutest2024-Q299.474.81—Buyer-sourced0PASS
AX-2024-004253SermorelinQYBQYB-2404-W4423VendorInvestigate2024-Q299.273.00100.9Buyer-sourced0PASS
AX-2024-005042LL-37SSASSA-2403-V6369PeptideMeter2024-Q298.071.8391.7Buyer-sourced0PASS
AX-2024-004774RetatrutideHomopeptideHOMO-2311-R5976Janoshik2024-Q298.623.11—Buyer-sourced0PASS
AX-2024-004551SemaglutideJEEPJEEP-2401-R8036Janoshik2024-Q299.148.39—Buyer-sourced0FAIL
AX-2024-005390RetatrutidePPGPPG-2311-F8058Janoshik2024-Q298.724.0595.1Buyer-sourced0PASS
AX-2024-005201GHRP-6CPCCPC-2401-N1934PeptideMeter2024-Q299.655.67—Buyer-sourced1MARGINAL
AX-2024-004979SemaglutideMKMMKM-2403-C4617Janoshik2024-Q299.476.1292.9Supplier-supplied1MARGINAL
AX-2024-004688MK-677 (Ibutamoren mesylate)HomopeptideHOMO-2401-J3421VendorInvestigate2024-Q299.274.4695.1Buyer-sourced0FAIL
AX-2024-004437SemaglutideGSPGSP-2405-W3331Medutest2024-Q298.533.25105.5Buyer-sourced0PASS